AAAAAA
Results: 1-25/238
Authors:
JENCK F
MOREAU JL
BERENDSEN HHG
BEES M
BROEKKAMP CLE
MARTIN JR
WICHMANN J
VANDELFT AML
Citation: F. Jenck et al., ANTIAVERSIVE EFFECTS OF 5HT(2C) RECEPTOR AGONISTS AND FLUOXETINE IN AMODEL OF PANIC-LIKE ANXIETY IN RATS, European neuropsychopharmacology, 8(3), 1998, pp. 161-168
Authors:
REDROBE JP
BOURIN M
Citation: Jp. Redrobe et M. Bourin, CLONIDINE POTENTIATES THE EFFECTS OF 5-HT1A, 5-HT1B AND 5-HT2A 2C ANTAGONISTS AND 8-OH-DPAT IN THE MOUSE FORCED SWIMMING TEST/, European neuropsychopharmacology, 8(3), 1998, pp. 169-173
Authors:
KORKMAZ S
CARLSSON S
WAHLSTROM G
Citation: S. Korkmaz et al., DEVELOPMENT OF PHYSICAL-DEPENDENCE TO LORAZEPAM IN RATS - THE EFFECTSOF REPEATED SHORT TREATMENTS, DOSE AND AGE, European neuropsychopharmacology, 8(3), 1998, pp. 175-181
Authors:
NATHAN PJ
BURROWS GD
NORMAN TR
Citation: Pj. Nathan et al., EVIDENCE FOR 5-HT1A RECEPTOR CONTROL OF PINEAL MELATONIN CONCENTRATIONS IN THE RAT, European neuropsychopharmacology, 8(3), 1998, pp. 183-186
Authors:
CARDENAS AM
VIZCARRA J
RAFFO M
PINCHEIRA R
INOSTROZA O
GARCIA R
Citation: Am. Cardenas et al., CLINICAL-EVALUATION OF THE EFFECT OF CALCIUM-CHANNEL BLOCKERS ON VERBAL-LEARNING, European neuropsychopharmacology, 8(3), 1998, pp. 187-189
Authors:
GERETSEGGER C
FARTACEK R
Citation: C. Geretsegger et R. Fartacek, INFUSIONAL HIGH-DOSE APPLICATION OF THE CALCIUM-CHANNEL-BLOCKING AND ANTIGLUTAMATERGIC AGENT CAROVERINE IN THE TREATMENT OF ALCOHOL-WITHDRAWAL (DSM-III-R-291.80), European neuropsychopharmacology, 8(3), 1998, pp. 191-194
Authors:
PALIT G
KUMAR R
CHOWDHURY SR
GUPTA MB
SAXENA RC
SRIMAL RC
DHAWAN BN
Citation: G. Palit et al., A PRIMATE MODEL OF ANXIETY, European neuropsychopharmacology, 8(3), 1998, pp. 195-201
Authors:
MIGUELHIDALGO JJ
VECINO B
FERNANDEZNOVOA L
ALVAREZ A
CACABELOS R
Citation: Jj. Miguelhidalgo et al., NEUROPROTECTIVE ROLE OF S12024 AGAINST NEURODEGENERATION IN THE RAT DENTATE GYRUS, European neuropsychopharmacology, 8(3), 1998, pp. 203-208
Authors:
LANGOSCH JM
REPP M
BERGER M
WALDEN J
Citation: Jm. Langosch et al., EFFECTS OF THE ATYPICAL ANTIDEPRESSANT TRIMIPRAMINE ON FIELD POTENTIALS IN THE LOW MG2-MODEL IN GUINEA-PIG HIPPOCAMPAL SLICES(), European neuropsychopharmacology, 8(3), 1998, pp. 209-212
Authors:
VEENING JG
COOLEN LM
SPOOREN WJPM
JOOSTEN H
VANOORSCHOT R
MOS J
RONKEN E
OLIVIER B
Citation: Jg. Veening et al., PATTERNS OF C-FOS EXPRESSION INDUCED BY FLUVOXAMINE ARE DIFFERENT AFTER ACUTE VS. CHRONIC ORAL-ADMINISTRATION, European neuropsychopharmacology, 8(3), 1998, pp. 213-226
Authors:
NALEPA I
MANIER DH
GILLESPIE DD
ROSSBY SP
SCHMIDT DE
SULSER F
Citation: I. Nalepa et al., LACK OF BETA-ADRENOCEPTOR DESENSITIZATION IN BRAIN FOLLOWING THE DUALNORADRENALINE AND SEROTONIN REUPTAKE INHIBITOR VENLAFAXINE, European neuropsychopharmacology, 8(3), 1998, pp. 227-232
Authors:
CZUCZWAR SJ
GASIOR M
KOZICKA M
PIETRASIEWICZ T
TURSKI WA
KLEINROK Z
Citation: Sj. Czuczwar et al., A POTENTIAL ANTIASTHMATIC DRUG, CR-2039, ENHANCES THE ANTICONVULSIVE ACTIVITY OF SOME ANTIEPILEPTIC DRUGS AGAINST PENTETRAZOL IN MICE, European neuropsychopharmacology, 8(3), 1998, pp. 233-238
Authors:
ALTAMURA AC
BIGNOTTI S
TURA G
CURRELI R
PIOLI R
Citation: Ac. Altamura et al., DEPRESSIVE SYMPTOMATOLOGY DURING CLOZAPINE TREATMENT - 2 CASE-REPORTS, European neuropsychopharmacology, 8(3), 1998, pp. 239-240
Citation: MEDICINAL PRODUCTS IN THE TREATMENT OF ALZHEIMERS-DISEASE, European neuropsychopharmacology, 8(3), 1998, pp. 241-245
Citation: THE CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF SCHIZOPHRENIA, European neuropsychopharmacology, 8(3), 1998, pp. 247-252
Authors:
BIENKOWSKI P
PIASECKI J
KOROS E
STEFANSKI R
KOSTOWSKI W
Citation: P. Bienkowski et al., STUDIES ON THE ROLE OF NICOTINIC ACETYLCHOLINE-RECEPTORS IN THE DISCRIMINATIVE AND AVERSIVE STIMULUS PROPERTIES OF ETHANOL IN THE RAT, European neuropsychopharmacology, 8(2), 1998, pp. 79-87
Authors:
KAREGE F
BOVIER P
STEPANIAN R
MALAFOSSE A
Citation: F. Karege et al., THE EFFECT OF CLINICAL OUTCOME ON PLATELET G-PROTEINS OF MAJOR DEPRESSED-PATIENTS, European neuropsychopharmacology, 8(2), 1998, pp. 89-94
Authors:
RODRIGUEZARIAS M
MINARRO J
AGUILAR MA
PINAZO J
SIMON VM
Citation: M. Rodriguezarias et al., EFFECTS OF RISPERIDONE AND SCH-23390 ON ISOLATION-INDUCED AGGRESSION IN MALE-MICE, European neuropsychopharmacology, 8(2), 1998, pp. 95-103
Authors:
SITGES M
GUARNEROS A
Citation: M. Sitges et A. Guarneros, CHRONIC VERAPAMIL MODIFIES STRIATAL AND FRONTAL-CORTEX DOPAMINE LEVELS, European neuropsychopharmacology, 8(2), 1998, pp. 105-111
Authors:
LAGOS P
SCORZA C
MONTI JM
JANTOS H
REYESPARADA M
SILVEIRA R
PONZONI A
Citation: P. Lagos et al., EFFECTS OF THE D-3 PREFERRING DOPAMINE AGONIST PRAMIPEXOLE ON SLEEP AND WAKING, LOCOMOTOR-ACTIVITY AND STRIATAL DOPAMINE RELEASE IN RATS, European neuropsychopharmacology, 8(2), 1998, pp. 113-120
Authors:
KORAN LM
PALLANTI S
PAIVA RS
QUERCIOLI L
Citation: Lm. Koran et al., PULSE LOADING VERSUS GRADUAL DOSING OF INTRAVENOUS CLOMIPRAMINE IN OBSESSIVE-COMPULSIVE DISORDER, European neuropsychopharmacology, 8(2), 1998, pp. 121-126
Authors:
EYLES DW
MCGRATH JJ
STEDMAN TJ
POND SM
Citation: Dw. Eyles et al., CHIRALITY OF REDUCED HALOPERIDOL IN HUMANS, European neuropsychopharmacology, 8(2), 1998, pp. 127-129
Authors:
GURGUIS GNM
TURKKA J
LINNOILA M
Citation: Gnm. Gurguis et al., EFFECTS OF SEROTONIN AND METERGOLINE ON (125)[I]-IODOCYANOPINDOLOL BINDING PARAMETERS TO BETA-ADRENERGIC RECEPTORS IN RAT-BRAIN, European neuropsychopharmacology, 8(2), 1998, pp. 131-140
Authors:
HERESCOLEVY U
JAVITT DC
Citation: U. Herescolevy et Dc. Javitt, THE ROLE OF N-METHYL-D-ASPARTATE (NMDA) RECEPTOR-MEDIATED NEUROTRANSMISSION IN THE PATHOPHYSIOLOGY AND THERAPEUTICS OF PSYCHIATRIC SYNDROMES, European neuropsychopharmacology, 8(2), 1998, pp. 141-152
Authors:
LOFBERG C
AGREN H
HARRO J
ORELAND L
Citation: C. Lofberg et al., CHOLECYSTOKININ IN CSF FROM DEPRESSED-PATIENTS - POSSIBLE RELATIONS TO SEVERITY OF DEPRESSION AND SUICIDAL-BEHAVIOR, European neuropsychopharmacology, 8(2), 1998, pp. 153-157